Dyslipidemia Treatment and Cardiovascular Disease in the Renal Patient

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|17|9|894-907

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.17, Iss.9, 2011-03, pp. : 894-907

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cardiovascular Disease and Dyslipidemia: Beyond LDL

By  

Current Pharmaceutical Design, Vol. 17, Iss. 9, 2011-03 ,pp. : 861-870

Bentham Science Publishers

Access to resources Recommend Favorite

Amlodipine/Atorvastatin Fixed-Dose Combination: A Review of its Use in the Prevention of Cardiovascular Disease and in the Treatment of Hypertension and Dyslipidemia

By McKeage Kate   Siddiqui M. Asif A.  

American Journal of Cardiovascular Drugs, Vol. 8, Iss. 1, 2008-01 ,pp. : 51-67

Adis International

Access to resources Recommend Favorite

The Role of Vitamin D in Dyslipidemia and Cardiovascular Disease

By  

Current Pharmaceutical Design, Vol. 17, Iss. 9, 2011-03 ,pp. : 933-942

Bentham Science Publishers

Access to resources Recommend Favorite

Treatment options for managing atherogenic dyslipidemia and fatty liver disease

By Rizzo Manfredi   Montalto Giuseppe   Al-Rasadi Khalid  

Expert Opinion on Pharmacotherapy, Vol. 15, Iss. 8, 2014-06 ,pp. : 1065-1068

Informa Healthcare

Access to resources Recommend Favorite

Torcetrapib: promising in the treatment of cardiovascular disease

By  

Inpharma, Vol. 1, Iss. 1434, 2004-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite